No two forms of cancer are the same – and not only because the disease can affect different organs. There are also different forms of liver cancer. Certain characteristics can vary from patient to patient. Researchers are developing medical tests for uncovering these differences. Blood and tissue samples are examined and genetic information collected in order to determine specific characteristics of the cancer. On the basis of this information it is then possible to treat patients with a specific drug that perfectly 'matches' the individual disease. This form of targeted treatment based on a previous diagnosis is called personalized medicine.
Bayer is engaged in the field of personalized medicine with the aim of developing targeted treatment options for patients.